0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Multi-Center Phase III Clinical Trials and NCI Cooperative Groups - Workshop Summary (Paperback, New) Loot Price: R1,215
Discovery Miles 12 150
Multi-Center Phase III Clinical Trials and NCI Cooperative Groups - Workshop Summary (Paperback, New): Institute of Medicine,...

Multi-Center Phase III Clinical Trials and NCI Cooperative Groups - Workshop Summary (Paperback, New)

Institute of Medicine, National Cancer Policy Forum; Edited by Christine Micheel, Sharyl Nass, Margie Patlak

 (sign in to rate)
Loot Price R1,215 Discovery Miles 12 150 | Repayment Terms: R114 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovative treatments that improve outcomes and quality of life. Despite these successes, the Cooperative Group Program has faced a number of challenges that threaten its effectiveness. To address this problem, the National Cancer Policy Forum (NCPF) convened a workshop titled "Multi-Center Phase III Clinical Trials and NCI Cooperative Groups" in Washington, DC, on July 1-2, 2008. The purpose of the workshop was to outline the challenges that the public clinical cancer research enterprise faces, and to identify possible solutions to these challenges. Table of Contents Front Matter Introduction Session 1A: Organization of the NCI Clinical Trials System Session 1B: Lessons from Non-Cooperative Group Multi-Center Clinical Trials Session 2: Barriers to Patient Recruitment and Physician Participation Session 3: Data Collection Standards and Monitoring Session 4: Costs of Cooperative Group Clinical Trials Summary and Wrap-Up References Abbreviations and Acronyms Glossary Appendix A: Workshop Agenda Appendix B: Workshop Speakers Appendix C: Letter from John Niederhuber, Director of the National Cancer Institute, to Members of the National Cancer Policy Forum

General

Imprint: National Academies Press
Country of origin: United States
Release date: March 2009
First published: 2009
Authors: Institute of Medicine • National Cancer Policy Forum
Editors: Christine Micheel • Sharyl Nass • Margie Patlak
Dimensions: 229 x 152 x 8mm (L x W x T)
Format: Paperback
Pages: 134
Edition: New
ISBN-13: 978-0-309-12867-4
Categories: Books > Medicine > General issues > Health systems & services > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 0-309-12867-6
Barcode: 9780309128674

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners